Medicinal Products for the Treatment of Blood Diseases, Hematopoietic Organs, and Cardiovascular System Diseases

This tender concerns the procurement of essential medicinal products for the treatment of blood diseases, hematopoietic organs, and cardiovascular system conditions. The specific items required include Digoxin, a solution for injection at a concentration of 0.25 mg/ml, supplied in 1 ml ampoules, and Dopamine, a concentrate for the preparation of infusion solutions at a concentration of 40 mg/ml, supplied in 5 ml ampoules. Both items fall under the CPV code 33620000-2, which pertains to cardiovascular system drugs.

The procuring entity is the COMMUNAL NON-PROFIT ENTERPRISE "KOROSTYSHIV CENTRAL DISTRICT HOSPITAL NAMED AFTER D.I. POTΕKHIN" OF THE KOROSTYSHIV CITY COUNCIL. This procurement is vital for ensuring the continued provision of critical medical care to patients requiring treatment for hematological and cardiovascular ailments within the Korostyshiv region. The tender aims to secure a reliable supply of these high-quality medications to meet the ongoing needs of the hospital's patients. Potential bidders are expected to provide products that meet stringent pharmaceutical standards and regulatory requirements. Further details regarding the specific quantities, delivery timelines, and evaluation criteria will be outlined in the full tender documentation.

This is a supplies contract in the health and medical services sector, with a focus on Hospitals and Pharmaceuticals. Located in Ukraine, Europe, this opportunity is open to firms and consortiums, with an estimated budget of UAH 12,200.

Published through ProZorro Ukraine, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.